CASP2 and ischemia: Furthermore, it was verified that the administration of broad-spectrum inhibitor targeting pro-apoptotic factors, including caspase-2, caspase-3 and caspase-7, at initial time of reperfusion could lead to shrunken size of post-ischemia infarct [40].